Search Results

There are 5364429 results for: content related to: Dopamine modulating drugs influence striatal (+)-[ 11 C]DTBZ binding in rats: VMAT2 binding is sensitive to changes in vesicular dopamine concentration

  1. Influence of a low dose of amphetamine on vesicular monoamine transporter binding: A PET (+)[11C]DTBZ study in humans


    Volume 64, Issue 6, June 2010, Pages: 417–420, Isabelle Boileau, Sylvain Houle, Pablo M. Rusjan, Yoshiaki Furukawa, Diana Wilkins, Junchao Tong, Peter Selby, Alan A. Wilson and Stephen J. Kish

    Version of Record online : 18 FEB 2010, DOI: 10.1002/syn.20743

  2. VMAT2 binding is elevated in dopa-responsive dystonia: Visualizing empty vesicles by PET


    Volume 49, Issue 1, July 2003, Pages: 20–28, Raúl De La Fuente-Fernández, Sarah Furtado, Mark Guttman, Yoshiaki Furukawa, Chong S. Lee, Donald B. Calne, Thomas J. Ruth and A. Jon Stoessl

    Version of Record online : 10 APR 2003, DOI: 10.1002/syn.10199

  3. Vesicular monoamine transporters: Structure-function, pharmacology, and medicinal chemistry

    Medicinal Research Reviews

    Volume 31, Issue 4, July 2011, Pages: 483–519, Kandatege Wimalasena

    Version of Record online : 4 FEB 2010, DOI: 10.1002/med.20187

  4. You have free access to this content
    Lobeline Displaces [3H]Dihydrotetrabenazine Binding and Releases [3H]Dopamine from Rat Striatal Synaptic Vesicles: Comparison with d-Amphetamine

    Journal of Neurochemistry

    Volume 71, Issue 1, July 1998, Pages: 258–265, LiHong Teng, Peter A. Crooks and Linda P. Dwoskin

    Version of Record online : 13 NOV 2002, DOI: 10.1046/j.1471-4159.1998.71010258.x

  5. Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging

    Annals of Neurology

    Volume 40, Issue 6, December 1996, Pages: 873–884, Dr. Kirk A. Frey, Robert A. Koeppe, Michael R. Kilbourn, Thierry M. Vander Borght, Roger L. Albin, Sid Gilman and David E. Kuhl

    Version of Record online : 16 OCT 2004, DOI: 10.1002/ana.410400609

  6. You have free access to this content
    VMAT2 quantitation by PET as a biomarker for β-cell mass in health and disease

    Diabetes, Obesity and Metabolism

    Volume 10, Issue s4, November 2008, Pages: 98–108, M. Freeby, R. Goland, M. Ichise, A. Maffei, R. Leibel and P. Harris

    Version of Record online : 2 OCT 2008, DOI: 10.1111/j.1463-1326.2008.00943.x

  7. You have free access to this content
    GZ-793A, a lobelane analog, interacts with the vesicular monoamine transporter-2 to inhibit the effect of methamphetamine

    Journal of Neurochemistry

    Volume 127, Issue 2, October 2013, Pages: 177–186, David B. Horton, Justin R. Nickell, Guangrong Zheng, Peter A. Crooks and Linda P. Dwoskin

    Version of Record online : 19 AUG 2013, DOI: 10.1111/jnc.12371

  8. Synthesis of (+)-α-[11C]Dihydrotetrabenazine ([11C]DTBZ)

    Radiochemical Syntheses: Radiopharmaceuticals for Positron Emission Tomography, Volume 1

    Peter J. H. Scott, Brian G. Hockley, Pages: 213–219, 2012

    Published Online : 4 JAN 2012, DOI: 10.1002/9781118140345.ch21

  9. You have free access to this content
    Analysis of VMAT2 Binding After Methamphetamine or MPTP Treatment

    Journal of Neurochemistry

    Volume 74, Issue 5, May 2000, Pages: 2217–2220, Kelly A. Hogan, Roland G. W. Staal and Patricia K. Sonsalla

    Version of Record online : 30 JUL 2008, DOI: 10.1046/j.1471-4159.2000.0742217.x

  10. Reduced MPTP neurotoxicity in striatum of the mutant mouse tottering


    Volume 30, Issue 2, October 1998, Pages: 205–210, Michael R. Kilbourn, Phillip Sherman and Louise C. Abbott

    Version of Record online : 7 DEC 1998, DOI: 10.1002/(SICI)1098-2396(199810)30:2<205::AID-SYN10>3.0.CO;2-0

  11. Synthesis and Biological Evaluation of 10-11C-Dihydrotetrabenazine as a Vesicular Monoamine Transporter 2 Radioligand

    Archiv der Pharmazie

    Volume 347, Issue 5, May 2014, Pages: 313–319, Xiaomin Li, Zhengping Chen, Jie Tang, Chunyi Liu, Pei Zou, Hongbo Huang, Cheng Tan and Huixin Yu

    Version of Record online : 3 FEB 2014, DOI: 10.1002/ardp.201300307

  12. Visualizing vesicular dopamine dynamics in Parkinson's disease


    Volume 63, Issue 8, August 2009, Pages: 713–716, Raúl de la Fuente-Fernández, Vesna Sossi, Siobhan McCormick, Michael Schulzer, Thomas J. Ruth and A. Jon Stoessl

    Version of Record online : 23 APR 2009, DOI: 10.1002/syn.20653

  13. In vivo measures of dopaminergic radioligands in the rat brain: Equilibrium infusion studies


    Volume 43, Issue 3, 1 March 2002, Pages: 188–194, Michael R. Kilbourn, Phillip S. Sherman and Kyle Kuszpit

    Version of Record online : 14 DEC 2001, DOI: 10.1002/syn.10039

  14. Neurofunctional imaging of β-cell dynamics

    Diabetes, Obesity and Metabolism

    Volume 14, Issue s3, October 2012, Pages: 91–100, P. E. Harris and R. L. Leibel

    Version of Record online : 28 AUG 2012, DOI: 10.1111/j.1463-1326.2012.01651.x

  15. PET radioligands for the vesicular transporters for monoamines and acetylcholine

    Journal of Labelled Compounds and Radiopharmaceuticals

    Volume 56, Issue 3-4, March-April 2013, Pages: 167–171, Michael R. Kilbourn

    Version of Record online : 24 APR 2013, DOI: 10.1002/jlcr.2998

  16. Dihydrotetrabenazine positron emission tomography imaging in early, untreated Parkinson's disease

    Annals of Neurology

    Volume 63, Issue 3, March 2008, Pages: 388–394, W. R. Wayne Martin, Marguerite Wieler, A. Jon Stoessl and Michael Schulzer

    Version of Record online : 31 JAN 2008, DOI: 10.1002/ana.21320

  17. VMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse

    Annals of the New York Academy of Sciences

    Volume 1216, Issue 1, January 2011, Pages: 86–98, Lee E. Eiden and Eberhard Weihe

    Version of Record online : 27 JAN 2011, DOI: 10.1111/j.1749-6632.2010.05906.x

  18. You have free access to this content
    A rapid oxidation and persistent decrease in the vesicular monoamine transporter 2 after methamphetamine

    Journal of Neurochemistry

    Volume 103, Issue 3, November 2007, Pages: 1219–1227, David J. Eyerman and Bryan K. Yamamoto

    Version of Record online : 17 JUL 2007, DOI: 10.1111/j.1471-4159.2007.04837.x

  19. You have free access to this content
    Increased MPTP Neurotoxicity in Vesicular Monoamine Transporter 2 Heterozygote Knockout Mice

    Journal of Neurochemistry

    Volume 70, Issue 5, May 1998, Pages: 1973–1978, Raul R. Gainetdinov, Fabio Fumagalli, Yan-Min Wang, Sara R. Jones, Allan I. Levey, Gary W. Miller and Marc G. Caron

    Version of Record online : 13 NOV 2002, DOI: 10.1046/j.1471-4159.1998.70051973.x

  20. Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users

    Annals of Neurology

    Volume 40, Issue 3, September 1996, Pages: 428–439, Julie M. Wilson, Kathleen Shannak, Dr Stephen J. Kish, Allan I. Levey, Catherine Bergeron, John Deck, Kathryn Kalasinsky, Lee Ang, Frank Peretti, Vernard I. Adams, John Smialek, William R. Anderson and Hyman B. Niznik

    Version of Record online : 8 OCT 2004, DOI: 10.1002/ana.410400312